Clinical correlates of JAK2 V617F point mutation in patients with chronic phase of myelofibrosis

Journal Title: Postępy Nauk Medycznych - Year 2011, Vol 24, Issue 7

Abstract

Introduction. Point mutation JAK2V617F occurs in 50-60% of patients with myelofibrosis (MF). Its clinical role is unclear and requires further studies.Material and methods. Seventy seven patients were included in the study, 41F/36M, at median age of 61 (range 19-81).Forty two patients were diagnosed with primary myelofibrosis (PMF), 16 with post-polycythemia vera myelofibrosis (post-PV MF)and 19 with post-essential thromocythemia myelofibrosis (post-ET MF). The JAK2V617F mutation was detected using allelic discrimination semi-quantitative real time polymerase chain reaction (test MutaScreenTM) from DNA of granulocytes from peripheral blood.Results. A total of 55% studied patients were JAK2-positive. The mutation was present in 50.88 and 37% of patients with PMF, post-PV MF and post-ET MF, respectively. JAK2 homozygosity was found in 57% of patients and heterozygosity in 43%. The median allele burden was 22 (range 2-96). JAK2 homozygosity was found to be seen more frequently in females, with higher white blood cell count and with tendency for higher hemoglobin concentration. There was no difference in overall survival between JAK2-positive and JAK2-negative patients as well as between homozygotes and heterozygotes.Conclusions. The presence of JAK2 mutation was demonstrated in 50-60% of patients with MF. It occurs more frequently in patients with post-PV MF. The correlation between JAK2 mutation status and overall survival was not found.

Authors and Affiliations

Agata Wieczorkiewicz-Kabut, Grzegorz Helbig, Krzysztof Woźniczka, Małgorzata Sobczyk-Kruszelnicka, Sławomira Kyrcz-Krzemień

Keywords

Related Articles

Typical and atypical symptoms of cardiac arrhythmias

Arrhythmic symptoms are the most important predictors of quality of life and cost-effectiveness of its treatment. Moreover, symptoms are the key point of non-invasive and invasive antiarrhythmic treatment for the managem...

Nietrzymanie stolca i gazów – problem wstydliwy, nieznany, niedoceniany. Znaczenie endosonografii

Przybliżone statystyki wskazują, że problem nietrzymania stolca i gazów (tj. inkontynencji) dotyczy 2-7% populacji dorosłej (do 40% > 65 r.ż.). Przeważającą liczbę stanowią kobiety, co wynika z różnic w budowie an...

Selected sociodemographic and clinical factors as predictors of suicide attempts with particular emphasis on poisoning

Suicidal tendencies occurring in humans are based on a combination of various factors including the areas of psychopathology, genetics, early life experiences, family and social interactions, stress, physical illness, an...

Environmental exposure to tobacco smoke and condition of organ of visio

According to the most recent epidemiological data, nicotine causes a greater number of addiction-related deaths than cocaine, heroin and alcohol combined. Its toxicity also significantly affects the organ of sight.Smokin...

Hereditary pancreatitis

Hereditary pancreatitis is a rare autosomal dominant disorder with a penetrance of approximately 80%. HP was first described in 1952 by Comfort and Steinberg, and in 1996 associated with PRSS1 gene mutation by Whitcomb e...

Download PDF file
  • EP ID EP54220
  • DOI -
  • Views 125
  • Downloads 0

How To Cite

Agata Wieczorkiewicz-Kabut, Grzegorz Helbig, Krzysztof Woźniczka, Małgorzata Sobczyk-Kruszelnicka, Sławomira Kyrcz-Krzemień (2011). Clinical correlates of JAK2 V617F point mutation in patients with chronic phase of myelofibrosis. Postępy Nauk Medycznych, 24(7), -. https://europub.co.uk/articles/-A-54220